Key result
Multivessel PCI staged during the index hospitalization reduced all-cause death compared with culprit vessel-only PCI in stable STEMI patients.
Why the study?
Multivessel PCI is recommended in STEMI and multivessel CAD without cardiogenic shock, but the optimal timing of multivessel PCI remained unclear.
Does multivessel PCI at different timings reduce all-cause death in stable STEMI patients with multivessel CAD compared to culprit vessel-only PCI?
Meta-Analysis (n=10,507)
Does multivessel PCI at different timings reduce all-cause death in stable STEMI patients with multivessel CAD compared to culprit vessel-only PCI?
In stable STEMI patients with multivessel CAD, multivessel PCI performed during the index hospitalization (either in a single procedure or staged) is the most efficacious approach, significantly reducing all-cause death compared to culprit-only PCI.
Answers are grounded in this paper and cite their sources.
Supports index-hospitalization multivessel PCI in stable multivessel STEMI; reinforces mortality benefit of complete revascularization.
Multivessel percutaneous coronary intervention (MV-PCI) is recommended in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) without cardiogenic shock. The present network meta-analysis investigated the optimal timing of MV-PCI in this context. We pooled the aggregated data from randomized trials investigating stable STEMI patients with multivessel CAD treated with a strategy of either MV-PCI or culprit vessel-only PCI. The primary outcome was all-cause death. The main secondary outcomes were cardiovascular death, myocardial infarction, and unplanned ischemia-driven revascularization. Among 11 trials, a total of 10 507 patients were randomly assigned to MV-PCI (same sitting, n = 1683; staged during the index hospitalization, n = 3460; staged during a subsequent hospitalization within 45 days, n = 3275) or to culprit vessel-only PCI (n = 2089). The median follow-up was 18.6 months. In comparison with culprit vessel-only PCI, MV-PCI staged during the index hospitalization significantly reduced all-cause death (risk ratio, 0.73; 95%CI, 0.56-0.92; P = .008) and ranked as possibly the best treatment option for this outcome compared with all other strategies. In comparison with culprit vessel-only PCI, a MV-PCI reduced cardiovascular mortality without differences dependent on the timing of revascularization. MV-PCI within the index hospitalization, either in a single procedure or staged, significantly reduced myocardial infarction and unplanned ischemia-driven revascularization, with no significant difference between each other. In patients with STEMI and multivessel CAD without cardiogenic shock, multivessel PCI within the index hospitalization, either in a single procedure or staged, represents the safest and most efficacious approach. The different timings of multivessel PCI did not result in any significant differences in all-cause death. This study is registered at PROSPERO (CRD42023457794). La intervención coronaria percutánea multivaso (ICPm) se recomienda para pacientes con infarto agudo de miocardio con elevación del segmento ST (IAMCEST) y enfermedad coronaria multivaso (ECMV) sin shock cardiogénico. El presente metanálisis en red investiga el momento óptimo para la ICPm en este contexto. Se agruparon los datos agregados de ensayos aleatorizados que estudiaron a pacientes con IAMCEST estable y ECMV tratados con una estrategia de ICPm o ICP solo del vaso culpable. El objetivo primario fue la muerte por cualquier causa. Los objetivos secundarios fueron la muerte cardiovascular, el infarto de miocardio y la revascularización no planificada por isquemia. Se aleatorizó a 10.507 pacientes de 11 ensayos a ICPm (misma sesión, n = 1.683; durante la hospitalización índice, n = 3.460; durante una hospitalización posterior en un plazo de 45 días, n = 3.275) o a ICP solo del vaso culpable (n = 2.089). La mediana de seguimiento fue de 18,6 meses. En comparación con la ICP solo del vaso culpable, la ICPm durante la hospitalización inicial redujo significativamente la mortalidad por cualquier causa (risk ratio = 0,73; IC95%, 0,56-0,92; p = 0,008) y se clasificó como la mejor opción de tratamiento para este resultado en comparación con todas las demás estrategias. En comparación con la ICP solo del vaso culpable, una ICPm redujo la mortalidad cardiovascular sin diferencias dependientes del momento de la revascularización. Una ICPm durante la hospitalización índice, ya fuera en un único procedimiento o escalonada, redujo significativamente los infartos de miocardio y las revascularizaciones no planificadas por isquemia y sin diferencias significativas estos. En pacientes con IAMCEST y ECMV sin shock cardiogénico, una ICPm durante la hospitalización índice, ya sea en un único procedimiento o de manera escalonada, es el abordaje más seguro y eficaz. Los distintos momentos de realización de la ICPm no mostraron diferencias significativas en muerte por todas las causas. El estudio está registrado en PROSPERO (CRD42023457794).
No takes yet. Share an insight, caveat, or question.
Voll et al. (2024) conducted a meta-analysis in ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) without cardiogenic shock (n=10,507). Multivessel percutaneous coronary intervention (MV-PCI) vs. Culprit vessel-only PCI was evaluated on All-cause death (RR 0.73, 95% CI 0.56-0.92, p=0.008). Multivessel PCI staged during the index hospitalization reduced all-cause death compared with culprit vessel-only PCI in stable STEMI patients.
Synapse has enriched 10 related papers. Consider them for comparative context: